1106 results for Support
Refine Your Search
Thomas
I was originally diagnosed with acute myeloid leukemia (AML) in November 2008. I went through one induction chemo and four rounds of consolidation che…
Camdon
My name is Camdon Cherry. I was 14 hours away from graduating with a BS in microbiology from Oklahoma State University when I was diagnosed with acute…
A phase 1/2 study of BI-1808, a monoclonal antibody to TNFR2, as a single agent and in combination with pembrolizumab in patients with solid tumors and CTCL
In January 2023, LLS made an equity investment in BioInvent to "Support Clinical Development of BI-1206 for NHL Indications and BI-1808 for T-Cell Lym…
Mayra
I am 28 years old and a mother of two. Last year on December 19, 2024, I was diagnosed with acute myeloid leukemia (AML), an aggressive blood cancer. …
Dare 2 Dream
Daniel (Lil Sicky)
Cancel blood cancer with web3! Daniel is a 27-year-old lymphoma patient who combined his medical diagnosis and love of digital art into an NFT project…
Max
Heads or tails? The medical research was clear. Soon after making his way into the world, this beautiful and innocent boy was given the chance of maki…
Deanna
Within 24 hours of going to the local emergency room in New York, I found myself being admitted to the Dana Farber/Brigham Women's Cancer Center in Bo…
Living with Acute Leukemia
Barclays Ajay Kataria is on a Mission to End Blood Cancer
Congratulations to Ajay Kataria, Head of BARX FX Sales, Americas, who was just awarded the ‘Citizenship Achievement of the Year – Americas’ at Barclay…
Student trailblazers, part 1: Enterprising teen engineers new way to deliver cancer treatment
One of my favorite things about being Chief Medical Officer of The Leukemia & Lymphoma Society (LLS) is getting to meet so many bright young people co…
How LLS and Advocates Helped Secure Landmark Health Reforms
Today, cancer patients—and others with other chronic conditions—are breathing a collective sigh of relief. After years of relentless efforts by LLS st…
Gwendolyn
Gwendolyn describes herself as a wanderlust who never likes to let the grass grow under her feet. After college, she moved from her hometown in Florid…
Suggested Reading - Coping with the Emotional Impact of Cancer: Become an Active Patient and Take Charge of Your Treatment
Coping with the Emotional Impact of Cancer: Become an Active Patient and Take Charge of Your Treatment By Neil Fiore Bay Tree Publishing, 2009, 178 P…
Suggested Reading - Instructional DVD: How to Give Comfort through Touch and Massage to a Loved One with Cancer
Instructional DVD: How to Give Comfort through Touch and Massage to a Loved One with Cancer By William Collinge, PhD, MPH 2009 A thorough and auth…
Suggested Reading - ACS Complete Guide to Nutrition for Cancer Survivors: Eating Well, Staying Well During and After Cancer
American Cancer Society Complete Guide to Nutrition for Cancer Survivors: Eating Well, Staying Well During and After Cancer by Abby S. Bloch PhD RD (E…
Christal
My brother was diagnosed with acute lymphoblastic leukemia (ALL) in September 1996 and passed away in April 1997, his senior year of high school and l…
A phase 1 expansion study of IO-202, an antibody targeting LILRB4, in combination with azacitidine in patients with monocytic differentiation AML and CMML
In March 2021, LLS made an equity investment in Immune-Onc Therapeutics to support the "Phase 1 Clinical Development of IO-202, An Antibody Targeting …
A phase 1 study of VIPER-101, a CD5-edited dual population chimeric antigen receptor cell therapy, to enhance immunotherapy against T-cell non-Hodgkin lymphoma
In October 2023, LLS made an equity investment in Vittoria to "Support Clinical Development of VIPER-101, a CAR-T Cell Therapy for T-cell lymphomas."V…
Milliman Report
Advocating for improved access to medications for patients.Blood Cancer United supports legislative efforts at both the state and federal level to lim…
Advocacy
Office of Cancer Complementary and Alternative Medicine (OCCAM)
OCCAM, a division of the National Cancer Institute (NCI), has the mission to improve the quality of care of cancer patients, as well as those at risk …
Giulia
A Leading Researcher Advancing Immunotherapy for Acute Myeloid LeukemiaIn Italy, Dr. Giulia Casorati is focused on adoptive cell immunotherapy to trea…
A phase 1 expansion study of IO-202, an antibody targeting LILRB4, in combination with azacitidine/venetoclax in patients with monocytic differentiation AML and CMML
In March 2021, LLS made an equity investment in Immune-Onc Therapeutics to support the "Phase 1 Clinical Development of IO-202, An Antibody Targeting …
Amber
I was diagnosed with stage 3 Hodgkin lymphoma (HL) right before my 27th birthday. I had just finished my Master’s degree and was engaged to get marrie…
Robert
I am a three-time survivor of Hodgkin lymphoma (HL). First, I received full mantle radiation therapy in 1986, followed by chemotherapy in 1994, and fi…
Paula
In the 1990’s, I was diagnosed with benign monoclonal gammopathy. In April 2013, I was experiencing severe back pain that lead me to the ER. The resul…
Avoiding Roadblocks in Coordinating CAR-T Therapy for B-cell Lymphoma: Practical Tips for Community Oncology Clinicians
Click Here to ParticipateCE Activity Release Date: March 25, 2022CE Activity Expiration Date: April 8, 2023Time to Complete Activity: 30 minutes0.5 CM…